Asia
Jiang Zhong Pharmaceutical's Profit Rises in Q1
Jiang Zhong Pharmaceutical (SHA:600750) posted net profit of 312 million yuan for the first quarter of 2026, up from 306.7 million yuan a year earlier, according to an April 24 Hong Kong bourse filing by parent China Resources Pharmaceutical (HKG:3320).Revenue fell to 1.04 billion yuan from 1.18 billion yuan.
SHA:600750
